These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28752982)

  • 1. [Sample Size Calculation using SAS for PhaseⅡin Two-stage Clinical Trials of Anti-tumor Drugs].
    Li JJ; Hou LS; Zhu P; Du XD; Zhu CR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):600-604. PubMed ID: 28752982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal and minimax three-stage designs for phase II oncology clinical trials.
    Chen K; Shan M
    Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal, minimax and admissible two-stage design for phase II oncology clinical trials.
    Qin F; Wu J; Chen F; Wei Y; Zhao Y; Jiang Z; Bai J; Yu H
    BMC Med Res Methodol; 2020 May; 20(1):126. PubMed ID: 32434577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal three-stage designs for phase II cancer clinical trials.
    Chen TT
    Stat Med; 1997 Dec; 16(23):2701-11. PubMed ID: 9421870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An optimal three-stage design for phase II clinical trials.
    Ensign LG; Gehan EA; Kamen DS; Thall PF
    Stat Med; 1994 Sep; 13(17):1727-36. PubMed ID: 7997706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimax and admissible adaptive two-stage designs in phase II clinical trials.
    Shan G; Zhang H; Jiang T
    BMC Med Res Methodol; 2016 Aug; 16():90. PubMed ID: 27485595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal flexible designs in phase II clinical trials.
    Chen TT; Ng TH
    Stat Med; 1998 Oct; 17(20):2301-12. PubMed ID: 9819829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On Simon's two-stage design for single-arm phase IIA cancer clinical trials under beta-binomial distribution.
    Liu J; Lin Y; Shih WJ
    Stat Med; 2010 May; 29(10):1084-95. PubMed ID: 20077506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admissible two-stage designs for phase II cancer clinical trials.
    Jung SH; Lee T; Kim K; George SL
    Stat Med; 2004 Feb; 23(4):561-9. PubMed ID: 14755389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review.
    Yoo W; Kim S; Garcia M; Mehta S; Sanai N
    BMC Med Res Methodol; 2022 Dec; 22(1):327. PubMed ID: 36550391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal two-stage designs for single arm phase II cancer trials.
    Shuster J
    J Biopharm Stat; 2002 Feb; 12(1):39-51. PubMed ID: 12146719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trials powered to detect tumor subtypes.
    Roberts JD; Ramakrishnan V
    Clin Cancer Res; 2011 Sep; 17(17):5538-45. PubMed ID: 21737510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive two-stage designs in phase II clinical trials.
    Banerjee A; Tsiatis AA
    Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials.
    Goffin JR; Pond GR; Tu D
    BMC Med Res Methodol; 2011 Jun; 11():95. PubMed ID: 21693051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flexible multi-stage design for phase II oncology trials.
    Tan MT; Xiong X
    Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multistage designs for phase II clinical trials: statistical issues in cancer research.
    Kramar A; Potvin D; Hill C
    Br J Cancer; 1996 Oct; 74(8):1317-20. PubMed ID: 8883425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G; Shih WJ; Moore D; Quan H; Marcella S
    Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimal two-stage phase II design utilizing complete and partial response information separately.
    Panageas KS; Smith A; Gönen M; Chapman PB
    Control Clin Trials; 2002 Aug; 23(4):367-79. PubMed ID: 12161080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal two-stage randomized phase II clinical trials.
    Logan BR
    Clin Trials; 2005; 2(1):5-12. PubMed ID: 16279574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-formulating Gehan's design as a flexible two-stage single-arm trial.
    Grayling MJ; Mander AP
    BMC Med Res Methodol; 2019 Jan; 19(1):22. PubMed ID: 30691398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.